Mohammad Almasri

Piemonte, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

Journal: Blood advances
Published: April 16, 2026

Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

Clonal hematopoiesis dynamics influences long-term outcomes of follicular lymphoma: Results from FIL FOLL12 trial.

Journal: HemaSphere
Published: February 04, 2026

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Dissecting clonal hematopoiesis in the myeloid compartment of chronic lymphocytic leukemia and Richter transformation.

Journal: HemaSphere
Published: July 22, 2025

Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.

Liquid Biopsy in B and T Cell Lymphomas: From Bench to Bedside.

Journal: International journal of molecular sciences
Published: April 18, 2025

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

The integration of gene mutations and copy number variations refines the prognosis of mantle cell lymphoma: long-term results of the Fondazione Italiana Linfomi MCL0208 clinical trial.

Journal: Leukemia
Published: March 04, 2025

Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Integration of [18F]FDG-PET radiomics with liquid biopsy improves outcome prediction in newly diagnosed diffuse large B-cell lymphoma.

Journal: Leukemia
Published: February 05, 2025

Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement.

Journal: Leukemia
Published: August 13, 2024

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Molecular clustering on ctDNA improves the prognostic stratification of patients with DLBCL compared with ctDNA levels.

Journal: Blood advances
Published: July 19, 2024

XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.

XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling.

Journal: British journal of haematology
Published: May 23, 2023

Liquid biopsy in hematological malignancies: current and future applications.

Liquid biopsy in hematological malignancies: current and future applications.

Journal: Frontiers in oncology
Published: February 12, 2023

Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.

Clonally unrelated Richter syndrome are truly de novo diffuse large B-cell lymphomas with a mutational profile reminiscent of clonally related Richter syndrome.

Journal: British journal of haematology
Published: May 21, 2022

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia.

Druggable Molecular Pathways in Chronic Lymphocytic Leukemia.

Journal: Life (Basel, Switzerland)
Published: December 24, 2021
Showing 1-12 of 12

Last Updated: 09/26/2026